Conditions: Melanoma; Brain Metastases
Interventions: Drug: Nivolumab; Drug: Ipilimumab
Sponsors: Melanoma Institute Australia; Melanoma and Skin Cancer Trials Limited; Bristol-Myers Squibb
Active, not recruiting
16576 items (16576 unread) in 74 feeds